P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

ABSTRACT:

SUBMITTER: Reiter A 

PROVIDER: S-EPMC9429350 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature